Clinical observation of minimally invasive vitrectomy assisted by Ranibizumab on severe proliferative diabetic retinopathy

Journal Title: Guoji Yanke Zazhi - Year 2018, Vol 18, Issue 8

Abstract

AIM: To investigate the clinical efficacy of 23G /25G minimally invasive vitrectomy assisted by intravitreal injection of Ranibizumab(IVR)in the treatment of severe proliferative diabetic retinopathy(PDR). <p>METHODS: The respective analysis of 56 eyes of 56 patients with severe PDR treated by minimally invasive vitrectomy from June 2014 to July 2016 was performed. Thirty eyes treated by IVR-assisted minimally invasive vitrectomy as Group A and 26 eyes treated by minimally invasive vitrectomy only as Group B. IVR(0.5mg/0.05mL)was performed on the eyes 5-7d before PPV in Group A. Operative duration, hemorrhage during the operation, endodiathermy times, incidence of iatrogenic retinal holes and best corrected visual acuity(BCVA)between the two groups were observed. The follow-up period was 6mo. <p>RESULTS: The average operation time in Group A was 98.10 ± 14.23min, Group B was 113.89±17.66min, the difference was statistically significant(<i>t</i>=3.703, <i>P</i>=0.0005). Hemorrhage during the operation was observed in 6 eyes in Group A(20%)and 14 eyes in Group B(54%), the difference was statistically significant(<i>χ</i><sup>2</sup>=6.95, <i>P</i>=0.0084). Endodiathermy time in Group A was significantly less than in Group B(1.30±1.15 <i>vs</i> 2.73±1.71; <i>t</i>=3.72, <i>P</i>=0.001). The incidence of iatrogenic retinal holes was observed in 2 eyes in Group A(7%)and 7 eyes in Group B(27%). The difference was statistically significant(<i>χ<sup>2</sup></i>=4.24, <i>P</i>=0.0396)in the two groups. The BCVA at post-operation 1mo was significantly improved in comparison with pre-operation, but no significant difference in the post-operative BCVA between the two groups(87% <i>vs </i>73%; <i>χ</i><sup>2</sup>=1.630, <i>P</i>=0.202). <p>CONCLUSION: Minimally invasive vitrectomy assisted with the preoperative intravitreal injection of ranibizumab in the treatment of severe PDR can effectively shorten the operation time, lessen the incidence of hemorrhage, endodiathermy time and iatrogenic retinal holes. No significant difference in the post-operative BCVA between the two groups.

Authors and Affiliations

Jin - Hua Xu

Keywords

Related Articles

Effectiveness and prognosis of 23G vitrectomy for perforating ocular trauma caused by metallic foreign bodies

AIM: To summarize the characteristics of ocular perforation caused by metallic foreign body, evaluate the effectiveness and safety of 23G vitrectomy, and analyze the factors that affect the final vision of patients with...

Comparative study on dry eyes after FS-LASIK, T-PRK and SMILE operations

AIM:To compare dry eye symptoms and signs before and after three kinds surgery, femtosecond laser-assisted laser <i>in situ</i> keratomileusis(FS-LASIK), transepithelial photorefractive keratectomy(T-PRK), small incision...

Efficacy of lacrimal duct probing for congenital dacryocystitis in 322 cases

AIM: To investigate the clinical effect of probing lacrimal passage for congenital dacryocystitis in children. <p>METHODS: Totally 322 children(361 eyes)with congenital dacryocystitis treated in our hospital from January...

Effects of amniotic membrane transplantation combined with limbal stem cell autograft transplantation on ocular burns

AIM: To investigate the effects of amniotic membrane transplantation combined with limbal stem cell autograft transplantation on ocular surface repair time, repair rate and complications in patients with ocular burns. <p...

The 24- hour pattern of intraocular pressure in suspected glaucoma patients

AIM: To analyze the value of 24-hour intraocular pressure(IOP)monitoring in suspected glaucoma patients.<p>METHODS: Totally 48 suspected glaucoma(96 eyes)were selected for 24-hour IOP monitoring by using Accupen tonomete...

Download PDF file
  • EP ID EP549289
  • DOI 10.3980/j.issn.1672-5123.2018.8.38
  • Views 105
  • Downloads 0

How To Cite

Jin - Hua Xu (2018). Clinical observation of minimally invasive vitrectomy assisted by Ranibizumab on severe proliferative diabetic retinopathy. Guoji Yanke Zazhi, 18(8), -. https://europub.co.uk/articles/-A-549289